Call Us
08045802327
Contact Us For Help
Change Language
Products
RESOF L

RESOF L

20 USD ($)/Box

Product Details:

  • Drug Type General Medicines
  • Physical Form Tablets
  • Dosage As Directed By Physician
  • Dosage Guidelines As Directed By Physician
  • Storage Instructions Dry Place
  • Click to View more
X

RESOF L Price And Quantity

  • 20 USD ($)/Box
  • 1000 Box

RESOF L Product Specifications

  • As Directed By Physician
  • Tablets
  • As Directed By Physician
  • Dry Place
  • General Medicines

RESOF L Trade Information

  • 1000000 Box Per Month
  • 1-2 Week
  • Australia Central America Middle East South America Eastern Europe Western Europe North America Asia Africa

Product Description

Product Details

Brand RESOF L

We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of RESOF L TABLET  Sofosbuvir 400mg  Ledipasvir 90mg  in different strength and packing Our manufacturing facility is certified with WHOGMP

COMPOSITION 

RESOF L TABLET  Sofosbuvir 400mg  Ledipasvir 90mg 
Brand name RESOF L
Active IngeridentsGeneric Name  Sofosbuvir 400mg  Ledipasvir 90mg
Company Name Dr Reddy
Strength  400 mg  90 mg
Package 28 tabs
Pack Type  Bottle
Indication

RESOF L  Contain Sofosbuvir and Ledipasvir For the treatment of Hepatitis C
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection ranging in severity from a mild illness lasting a few weeks to a serious lifelong illness
The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices inadequate sterilization of medical equipment and the transfusion of unscreened blood and blood products
Globally between 130150 million people globally have chronic hepatitis C infection
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer
There is currently no vaccine for hepatitis C however research in this area is ongoing
The hepatitis C virus is a bloodborne virus It is most commonly transmitted through
injecting drug use through the sharing of injection equipment
the reuse or inadequate sterilization of medical equipment especially syringes and needles in healthcare settings and
the transfusion of unscreened blood and blood products
Uses
Treating chronic hepatitis C virus HCV infection in certain patients
Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus HCV antiviral agents It reduces the amount of HCV in the body by preventing the spread of the HCV within the body

Available other Brand  HEPCINAT LP LEDIFOS LEDVICLEAR MYHEP LVIR HEPCVIR L  SOFOCURE L NOVISOF L LEDIHEP SOFAB LP LEDVICLEAR SOFOCRUZ LP SOFOKEM L CIMIVIR L

We are manufacture and export our brandWe also offer private labelling Contract manufacturing service
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Hepatitis C Medicine' category